China proposes curbs on foreign purchases of critical biopharma technology
China is proposing new restrictions on foreign acquisitions involving critical biopharma technologies as it seeks to keep control of its drug development industry. The proposal was reported on Oct. 19, 2026, but the available reporting does not spell out the…
